Recall: D-0877-2026
Class II - Potentially Harmful
Class IIClassification
2026-09-23Initiated
OngoingStatus
Apotex Corp.Firm
Product
Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3
Reason
Failed dissolution specifications.
Distribution
US Nationwide.
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.